Updates
Pfizer Ltd has now informed BSE that the Company has intimated the concerned authorities that it has withdrawn its notice dated July 15, 2015, whereby it had intended to effect closure of its plant situated at Thane Belapur Road, K.U. Bazar P. O., Navi Mumbai - 400075 ("the Plant"), as the Company has entered into a Business Transfer Agreement to sell the Plant as a going concern to Vidhi Research & Development LLP.
Pfizer to sell Thane plant for Rs178 crore
All workmen at the plant will be transferred to the buyer to facilitate manufacturing operations Updates
Pfizer Ltd has informed BSE that it has entered into a Business Transfer Agreement (BTA) for the transfer of the Company's business at the Thane Plant as a going concern to Vidhi Research and Development LLP in accordance with the terms of the agreement for a lump sum consideration of Rs. 178 crores. Upon the conclusion of the BTA, all current workmen at the Thane Plant shall be transferred to the buyer so as to facilitate manufacturing operations.
India rejects patent on Pfizers arthritis drug
Pfizer sought a patent that covers an important chemical formulation of the active compound in the medicine Pfizers stop-smoking drug Chantix not linked to depression or heart risks
Pfizer's stop-smoking drug Chantix does not raise risks of heart attack or depression, contrary to previous reports, and should be recommended to more smokers wanting to quit, scientists said on Monday. Pfizer Completes Acquisition of Hospira
Pfizer Ltd has informed BSE that the Company has been informed by its parent company Pfizer Inc. that it has concluded its acquisition of Hospira Inc. (a Lake Forest, IL based company, previously traded on the New York Stock Exchange).A copy of the press release issued by Pfizer Inc. describing this transaction is enclosed. Resignation of Executive Director
Pfizer Ltd has informed BSE that Dr. Lakshmi Nadkarni, Executive Director - Human Resources has resigned from the Board of the Company effective close of business hours on September 04, 2015. Female Viagra Addyi seen more a pace-setter than moneymaker for Sprout Pharmaceuticals
The first U.S. treatment for low sexual desire in women, dubbed "female Viagra," is more likely to help build a market for better future rival drugs than achieve the sales seen for Pfizer Inc's famous little blue pill for men, industry experts said. Outcome of AGM
Pfizer Ltd has submitted to BSE a copy of Minutes of the 64th Annual General Meeting of the Company held on July 13, 2015. Britain raps Pfizer over inflated epilepsy drug prices
Britain's competition watchdog alleged on Thursday that U.S. drugmaker Pfizer and Flynn Pharma had breached competition law by ramping up the cost of an epilepsy drug used by more than 50,000 British patients.